News2 mins ago
OnQuality Announces FDA Clearance of IND Application for OQL051, for the Prophylaxis of Chemotherapy-Induced Diarrhea
SEATTLE, June 6, 2023 /PRNewswire/ — OnQuality Pharmaceuticals (“OnQuality”), a targeted oncology supportive therapy company developing innovative medications to address unmet needs in oncodermatology and oncogastroenterology...
